Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s share price passed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of C$0.19 and traded as low as C$0.18. Theralase Technologies shares last traded at C$0.18, with a volume of 40,902 shares trading hands.
Theralase Technologies Price Performance
The company has a debt-to-equity ratio of 2.17, a quick ratio of 3.40 and a current ratio of 5.48. The stock has a market cap of C$55.89 million, a PE ratio of -12.86 and a beta of -1.01. The stock’s 50-day moving average is C$0.19 and its two-hundred day moving average is C$0.24.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Stories
- Five stocks we like better than Theralase Technologies
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
